Marketplace · Netherlands
Healthcare & medical practice businesses in Almere typically transact at 4.7x–7.0x EV/EBITDA, with a sector median of 5.8x in the Netherlands. Young, fast-growing city in Flevoland.
Almere (population ~220,000, Flevoland) anchors healthcare & medical practice transactions at a 5.8x EV/EBITDA median, with most defensible deals landing between 4.7x (conservative) and 7.0x (strong recurring revenue). Young, fast-growing city in Flevoland. SMEs lean towards consumer services, retail, construction and home-services; transactions often involve Amsterdam-area buyer pools.
Upswitch is anonymity-by-design — new healthcare & medical practice dossiers in Almere surface here as soon as they pass advisor validation. Subscribe to the alert and we'll notify you within hours of the next listing going live.
Browse all listingsFor a healthcare & medical practice SME in Almere with normalised EBITDA above €200k, expect the headline price to anchor on a 5.8x EV/EBITDA multiple, with a working-capital peg, 5–15% escrow, and (in 35–45% of deals) an earn-out tied to year-one EBITDA or customer retention. Cross-border buyer interest from Belgian acquirers is consistently elevated.
Young, fast-growing city in Flevoland. SMEs lean towards consumer services, retail, construction and home-services; transactions often involve Amsterdam-area buyer pools. For healthcare & medical practice specifically, Almere's buyer pool typically includes regional family businesses, Benelux-wide strategic acquirers, and (for deals above ~€2m EV) PE-backed roll-up platforms.